ABUS Operating Cash Flow (Statement)
Arbutus Biopharma Corp · Operating Cash Flow (Statement)
ABUS Operating Cash Flow (Statement)
Latest reported-$6.02Mperiod ending
ABUS Quarterly Cash from Operations (-$1.45M → -$6.02M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
ABUS operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -6,018,000 | |
| -8,109,999 | |
| -4,680,000 | |
| -5,817,000 | |
| -15,749,000 | |
| -13,391,000 | |
| -10,315,000 | |
| -20,736,000 | |
| -14,504,000 | |
| -19,295,000 | |
| -17,292,000 | |
| -21,784,000 | |
| -19,559,000 | |
| -27,301,000 | |
| -16,990,000 | |
| -18,692,000 | |
| -20,293,000 | |
| 20,619,000 | |
| -19,606,000 | |
| -16,036,000 | |
| -14,009,000 | |
| -17,881,000 | |
| -15,013,000 | |
| -12,174,000 | |
| -8,801,000 | |
| -15,453,000 | |
| -13,351,000 | |
| -23,470,000 | |
| -17,605,000 | |
| -16,580,000 | |
| -17,075,000 | |
| -13,204,000 | |
| -17,622,000 | |
| -19,967,000 | |
| -10,342,000 | |
| -15,680,000 | |
| -5,078,000 | |
| -17,535,000 | |
| -14,822,000 | |
| -14,712,000 | |
| -16,804,000 | |
| -11,546,000 | |
| -16,617,000 | |
| -2,527,000 | |
| -16,671,000 | |
| -17,843,000 | |
| -6,846,000 | |
| -6,720,000 | |
| -8,010,000 | |
| 9,155,000 | |
| 2,553,037 | |
| -3,640,643 | |
| -2,779,931 | |
| -2,854,665 | |
| 40,719,863 | |
| -1,315,318 | |
| -1,755,333 | |
| -4,261,779 | |
| -135,980 | |
| -59,985 | |
| -4,177,420 | |
| -3,147,284 | |
| -3,781,805 | |
| -2,290,496 | |
| 79,434 | |
| -5,253,841 | |
| -1,763,966 | |
| -947,746 | |
| -1,640,264 | |
| -887,027 | |
| -1,677,434 | |
| -3,381,817 | |
| -2,805,239 | |
| -619,839 | |
| 1,033,325 | |
| -1,451,673 |